Pharm Company: * AMNEAL PHARMS NY
Category: Irritable Bowel Syndrome

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lubiprostone Overview

Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company. The drug was developed by Sucampo Pharmaceuticals and approved by the Food and Drug Administration (FDA) in 2006.[1][2][3...

Read more Lubiprostone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Lubiprostone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 24mcg, 24ugm, 8mcg, 8ugm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lubiprostone: (2 results)

Sorted by National Drug Code
  • 0254-3028 Lubiprostone 8 ug/1 Oral Capsule, Gelatin Coated by Par Pharmaceutical Inc.
  • 0254-3029 Lubiprostone 24 ug/1 Oral Capsule, Gelatin Coated by Par Pharmaceutical Inc.

Other drugs which contain Lubiprostone or a similar ingredient: (1 result)